4//SEC Filing
Chambers Michael Andrew 4
Accession 0000950170-24-026613
CIK 0000873303other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:00 PM ET
Size
7.7 KB
Accession
0000950170-24-026613
Insider Transaction Report
Form 4
Chambers Michael Andrew
Director
Transactions
- Award
Common Stock
2024-03-01+1,846→ 8,277 total - Award
Stock Option (right to buy)
2024-03-01+3,679→ 3,679 totalExercise: $128.67From: 2025-03-01Exp: 2034-03-01→ Common Stock (3,679 underlying)
Holdings
- 246,996(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001932527
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 8:00 PM ET
- Size
- 7.7 KB